MB Therapeutics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series A
  • (Cancelled)

  • Investors
  • 6

MB Therapeutics General Information

Description

Operator of a pharmaceutical company intended to provide personalized medicine through healthcare three-D printing. The company offers patient-centric system for developing and producing customized medicines as well as evaluation services and specializes in customizing medication dosage, forms, and combining multiple active ingredients into a single unit, enabling healthcare professionals to enhance treatment precision and improving patient adherence.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 505b, Rue Louis Lepine
  • 34000 Montpellier
  • France
+33 06
Primary Industry
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 505b, Rue Louis Lepine
  • 34000 Montpellier
  • France
+33 06

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MB Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 24-Feb-2025 Cancelled Generating Revenue
3. Early Stage VC Completed Generating Revenue
2. Early Stage VC 24-Feb-2025 $2.08M $2.08M Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2023 Completed Startup
To view MB Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

MB Therapeutics Patents

MB Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025247979-A1 Extrusion-printable pharmaceutical formulation, print cartridge containing such a formulation and method for preparing a medicament using same Pending 30-May-2024
FR-3162625-A1 Extrusion-printable pharmaceutical formulation, printing cartridge containing such a formulation, and process for preparing a medicinal product using it Pending 30-May-2024

MB Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MB Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angels Santé Angel Group Minority
Banque Publique d'Investissement Investment Bank Minority
Beprep Venture Capital Minority
Calyseed Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 6 investors. Get the full list »

MB Therapeutics FAQs

  • When was MB Therapeutics founded?

    MB Therapeutics was founded in 2023.

  • Where is MB Therapeutics headquartered?

    MB Therapeutics is headquartered in Montpellier, France.

  • What is the size of MB Therapeutics?

    MB Therapeutics has 10 total employees.

  • What industry is MB Therapeutics in?

    MB Therapeutics’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is MB Therapeutics a private or public company?

    MB Therapeutics is a Private company.

  • What is MB Therapeutics’s current revenue?

    The current revenue for MB Therapeutics is .

  • How much funding has MB Therapeutics raised over time?

    MB Therapeutics has raised $2.67M.

  • Who are MB Therapeutics’s investors?

    Angels Santé, Banque Publique d'Investissement, Beprep, Calyseed, and are 5 of 6 investors who have invested in MB Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process